Thema: VYNE Therapeutics

VYNE Therapeutics, US92941V1008

VYNE Therapeutics (ISIN: US92941V1008) shares climbed 6.82% on NASDAQ to close at $0.6246 USD fueled ...

Gemini_Generated_Image_65ot5v65ot5v65ot.png - Foto: THN
Gemini_Generated_Image_65ot5v65ot5v65ot.png - Foto: THN

VYNE Therapeutics stock rises amid biotech volatility and merger talks

ad-hoc-news.de, 20.03.26 15:13 Uhr